How Will We Pay For Miracle Cures?

The video discusses the potential of gene therapy treatments for sickle cell anemia, highlighting the challenges of making these treatments accessible and affordable. It covers the treatment process, cost implications, and the roles of various stakeholders in addressing these issues. The economic impact on public insurers and the need for innovative payment models are also explored, emphasizing the importance of ensuring that new therapies reach those in need.

What potential benefits could arise from state Medicaid plans covering gene therapy treatments?

What are the implications of failing to develop a payment model for gene therapies?